4 results match your criteria: "Cancer Chemotherapy Centre[Affiliation]"
Br J Haematol
November 2018
Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Br J Cancer
May 2009
Division of Molecular Biotherapy, Cancer Chemotherapy Centre, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.
Enhanced lipid biosynthesis is a characteristic feature of cancer. Deregulated lipogenesis plays an important role in tumour cell survival. These observations suggest that enzymes in the lipid synthesis pathway would be rational therapeutic targets for cancer.
View Article and Find Full Text PDFLeuk Lymphoma
February 2002
Division of Clinical Chemotherapy, Cancer Chemotherapy Centre, Japanese Foundation for Cancer Research, Tokyo.
We performed double autologous PBSCT in one fulminantly relapsed ATL patient. Cryopreserved PBSCs containing tumour cells were thawed, and CD34+ cells were selected for by immunomagnetic beads, with the aim of decreasing the number of re-infused tumour cells. The patient received 0.
View Article and Find Full Text PDFLeuk Lymphoma
August 2001
Division of Clinical Chemotherapy, Cancer Chemotherapy Centre, Japanese Foundation for Cancer Research, Tokyo, Japan.
An unusual association of paroxysmal nocturnal haemoglobinuria (PNH), myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML) and monoclonal gammopathy is reported. A 60-year old male, who had a history of IgA monoclonal gammopathy, presented with haemoglobinuria and colic pain. Flow cytometry showed CD55negative/59dim peripheral red cells, and bone marrow examination disclosed MDS.
View Article and Find Full Text PDF